1
|
Akompong SK, Li Y, Gong W, Ye L, Liu J. Recently reported cell migration inhibitors: Opportunities and challenges for antimetastatic agents. Drug Discov Today 2024; 29:103906. [PMID: 38309689 DOI: 10.1016/j.drudis.2024.103906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 01/17/2024] [Accepted: 01/25/2024] [Indexed: 02/05/2024]
Abstract
Antimetastatic agents are highly desirable for cancer treatment because of the severe medical challenges and high mortality resulting from tumor metastasis. Having demonstrated antimetastatic effects in numerous in vitro and in vivo studies, migration inhibitors present significant opportunities for developing a new class of anticancer drugs. To provide a useful overview on the latest research in migration inhibitors, this article first discusses their therapeutic significance, targetable proteins, and developmental avenues. Subsequently it reviews over 20 representative migration inhibitors reported in recent journals in terms of their inhibitory mechanism, potency, and potential clinical utility. The relevance of the target proteins to cellular migratory function is focused on as it is crucial for assessing the overall efficacy of the inhibitors.
Collapse
Affiliation(s)
- Samuel K Akompong
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China
| | - Yang Li
- Zhongnan Hospital of Wuhan University, Wuhan 430071, China
| | - Wenxue Gong
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China
| | - Long Ye
- School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
| | - Jinping Liu
- Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
| |
Collapse
|
2
|
Pandimeena G, Mathavan T, Samuel EJJ, Milton Franklin Benial A. Quantum chemical, spectroscopic and molecular docking investigations of potential pulmonary fibrosis drug methyl 2-chloro 4-iodonicotinate. J Mol Recognit 2023; 36:e3001. [PMID: 36315423 DOI: 10.1002/jmr.3001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 10/14/2022] [Accepted: 10/26/2022] [Indexed: 11/06/2022]
Abstract
In this work, the methyl 2-chloro 4-iodonicotinate (MCIN) was investigated to study the structural, spectroscopic and electronic properties using density functional theory (DFT) quantum chemical calculations. The most stable structure of MCIN was optimized by DFT/B3LYP method with a LanLD2Z basis set. The optimized parameters and vibrational wavenumbers were determined. The vibrational task of the molecule was done by potential energy distribution calculations. The 13 C NMR spectrum of the MCIN molecule was simulated by the Gauge-Invariant-Atomic Orbital method using a dimethyl sulfoxide solution and the isotropic chemical shift values of the molecule were calculated and observed. Ultraviolet-visible spectra were simulated and observed. The pharmaceutical activity was predicted using frontier molecular orbital and natural bond orbital analysis. The reactive sites of the MCIN molecule were determined using Mulliken atomic charge distribution, molecular electrostatic potential surface and the local reactivity analysis. The molecular docking analysis confirms that the title molecule can be used in drug design for the treatment of pulmonary fibrosis.
Collapse
Affiliation(s)
- G Pandimeena
- P.G. & Research Department of Physics, N.M.S.S.V.N. College, Madurai, India
| | - T Mathavan
- P.G. & Research Department of Physics, N.M.S.S.V.N. College, Madurai, India
| | - E James Jebaseelan Samuel
- Department of Physics, School of Advanced Sciences, Vellore Institute of Technology (VIT) university, Vellore, India
| | | |
Collapse
|
3
|
Wusiman W, Zhang Z, Ding Q, Liu M. The pathophyiological role of aminoacyl-tRNA synthetases in digestive system diseases. Front Physiol 2022; 13:935576. [PMID: 36017335 PMCID: PMC9396140 DOI: 10.3389/fphys.2022.935576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Accepted: 07/05/2022] [Indexed: 12/24/2022] Open
Abstract
Aminoacyl-tRNA synthetases (ARSs) catalyze the ligation of amino acids to their cognate transfer RNAs and are indispensable enzymes for protein biosynthesis in all the cells. Previously, ARSs were considered simply as housekeeping enzymes, however, they are now known to be involved in a variety of physiological and pathological processes, such as tumorigenesis, angiogenesis, and immune response. In this review, we summarize the role of ARSs in the digestive system, including the esophagus, stomach, small intestine, colon, as well as the auxiliary organs such as the pancreas, liver, and the gallbladder. Furthermore, we specifically focus on the diagnostic and prognostic value of ARSs in cancers, aiming to provide new insights into the pathophysiological implications of ARSs in tumorigenesis.
Collapse
Affiliation(s)
- Wugelanmu Wusiman
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Zerui Zhang
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Qiang Ding
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Mei Liu
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- *Correspondence: Mei Liu,
| |
Collapse
|
4
|
Tahir T, Tabassum R, Javed Q, Ali A, Ashfaq M, Shahzad MI. Synthesis, kinetics, structure-activity relationship and in silico ADME studies of new diazenyl azo-phenol derivatives against urease, SARS-CoV-2 main protease (Mpro) and ribosomal protein S1 (RpsA) of Mycobacterium tuberculosis. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.132336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
5
|
Khan K, Gogonea V, Fox PL. Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis. Transl Oncol 2022; 19:101392. [PMID: 35278792 PMCID: PMC8914993 DOI: 10.1016/j.tranon.2022.101392] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Revised: 02/27/2022] [Accepted: 02/28/2022] [Indexed: 12/16/2022] Open
Abstract
In mammalian cells, 20 aminoacyl-tRNA synthetases (AARS) catalyze the ligation of amino acids to their cognate tRNAs to generate aminoacylated-tRNAs. In higher eukaryotes, 9 of the 20 AARSs, along with 3 auxiliary proteins, join to form the cytoplasmic multi-tRNA synthetase complex (MSC). The complex is absent in prokaryotes, but evolutionary expansion of MSC constituents, primarily by addition of novel interacting domains, facilitates formation of subcomplexes that join to establish the holo-MSC. In some cases, environmental cues direct the release of constituents from the MSC which enables the execution of non-canonical, i.e., "moonlighting", functions distinct from their essential activities in protein translation. These activities are generally beneficial, but can also be deleterious to the cell. Elucidation of the non-canonical activities of several AARSs residing in the MSC suggest they are potential therapeutic targets for cancer, as well as metabolic and neurologic diseases. Here, we describe the role of MSC-resident AARSs in cancer progression, and the factors that regulate their release from the MSC. Also, we highlight recent developments in therapeutic modalities that target MSC AARSs for cancer prevention and treatment.
Collapse
Affiliation(s)
- Krishnendu Khan
- Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.
| | - Valentin Gogonea
- Department of Chemistry, Cleveland State University, Cleveland, OH 44115, United States of America
| | - Paul L Fox
- Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, United States of America.
| |
Collapse
|
6
|
Sim J, Lanka S, Jo JW, Chaudhary CL, Vishwanath M, Jung CH, Lee YH, Kim EY, Kim YS, Hyun SS, Lee HS, Lee K, Seo SY, Viji M, Jung JK. Inhibitory Effect of Chlorogenic Acid Analogues Comprising Pyridine and Pyrimidine on α-MSH-Stimulated Melanogenesis and Stability of Acyl Analogues in Methanol. Pharmaceuticals (Basel) 2021; 14:1176. [PMID: 34832958 PMCID: PMC8622415 DOI: 10.3390/ph14111176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 11/11/2021] [Accepted: 11/14/2021] [Indexed: 11/30/2022] Open
Abstract
In continuation of studies for α-MSH stimulated melanogenesis inhibitors, we have evaluated the design, synthesis, and activity of a new series of chlorogenic acid (CGA) analogues comprising pyridine, pyrimidine, and diacyl derivatives. Among nineteen synthesized compounds, most of them (fifteen) exhibited better inhibitions of melanin formation in B16 melanoma cells. The results illustrated that a pyridine analogue 6f and a diacyl derivative 13a of CGA showed superior inhibition profiles (IC50: 2.5 ± 0.7 μM and 1.1 ± 0.1 μM, respectively) of α-MSH activities than positive controls, kojic acid and arbutin (IC50: 54 ± 1.5 μM and 380 ± 9.5 μM, respectively). The SAR studies showed that both -CF3 and -Cl groups exhibited better inhibition at the meta position on benzylamine than their ortho and para positions. In addition, the stability of diacyl analogues of CGA in methanol monitored by HPLC for 28 days indicated the steric bulkiness of acyl substituents as a key factor in their stability.
Collapse
Affiliation(s)
- Jaeuk Sim
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Srinu Lanka
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Jeong-Woong Jo
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Chhabi Lal Chaudhary
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Manjunatha Vishwanath
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Chan-Hyun Jung
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Young-Hee Lee
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
- Samjin Central Research Institute, Samjin Pharma Co., Ltd., Cheongju 28158, Korea
| | - Eun-Yeong Kim
- College of Pharmacy, Korea University, Sejong 30019, Korea; (E.-Y.K.); (K.L.)
| | - Young-Soo Kim
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Soon-Sil Hyun
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Hee-Soon Lee
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Kiho Lee
- College of Pharmacy, Korea University, Sejong 30019, Korea; (E.-Y.K.); (K.L.)
| | - Seung-Yong Seo
- Gachon Institute of Pharmaceutical Sciences, College of Pharmacy, Gachon University, Incheon 21936, Korea;
| | - Mayavan Viji
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| | - Jae-Kyung Jung
- College of Pharmacy and Medicinal Research Center (MRC), Chungbuk National University, Cheongju 28160, Korea; (J.S.); (S.L.); (J.-W.J.); (C.L.C.); (M.V.); (C.-H.J.); (Y.-H.L.); (Y.-S.K.); (S.-S.H.); (H.-S.L.)
| |
Collapse
|
7
|
Pyridine Scaffolds, Phenols and Derivatives of Azo Moiety: Current Therapeutic Perspectives. Molecules 2021; 26:molecules26164872. [PMID: 34443460 PMCID: PMC8399416 DOI: 10.3390/molecules26164872] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Revised: 08/07/2021] [Accepted: 08/09/2021] [Indexed: 11/24/2022] Open
Abstract
Synthetic heterocyclic compounds have incredible potential against different diseases; pyridines, phenolic compounds and the derivatives of azo moiety have shown excellent antimicrobial, antiviral, antidiabetic, anti-melanogenic, anti-ulcer, anticancer, anti-mycobacterial, anti-inflammatory, DNA binding and chemosensing activities. In the present review, the above-mentioned activities of the nitrogen-containing heterocyclic compounds (pyridines), hydroxyl (phenols) and azo derivatives are discussed with reference to the minimum inhibitory concentration and structure–activity relationship, which clearly indicate that the presence of nitrogen in the phenyl ring; in addition, the hydroxyl substituent and the incorporation of a diazo group is crucial for the improved efficacies of the compounds in probing different diseases. The comparison was made with the reported drugs and new synthetic derivatives that showed recent therapeutic perspectives made in the last five years.
Collapse
|